127 related articles for article (PubMed ID: 18198998)
41. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
42. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
43. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
Wang Z; Hu L; Salari K; Bechis SK; Ge R; Wu S; Rassoulian C; Pham J; Wu CL; Tabatabaei S; Strand DW; Olumi AF
J Pathol; 2017 Dec; 243(4):457-467. PubMed ID: 28940538
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog.
Crescioli C; Ferruzzi P; Caporali A; Mancina R; Comerci A; Muratori M; Scaltriti M; Vannelli GB; Smiroldo S; Mariani R; Villari D; Bettuzzi S; Serio M; Adorini L; Maggi M
Endocrinology; 2003 Jul; 144(7):3046-57. PubMed ID: 12810561
[TBL] [Abstract][Full Text] [Related]
45. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
46. CGP 53153: a new potent inhibitor of 5alpha-reductase.
Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
[TBL] [Abstract][Full Text] [Related]
47. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623
[TBL] [Abstract][Full Text] [Related]
48. Influence of androgens and age on androgen receptor and 5 alpha-reductase II transcription.
Hellwinkel OJ; Müller A; Struve D; Hiort O
Eur J Endocrinol; 2000 Aug; 143(2):217-25. PubMed ID: 10913941
[TBL] [Abstract][Full Text] [Related]
49. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells.
Lee HH; Ho CT; Lin JK
Carcinogenesis; 2004 Jul; 25(7):1109-18. PubMed ID: 14963012
[TBL] [Abstract][Full Text] [Related]
50. Steroids with a carbamate function at C-17, a novel class of inhibitors for human and hamster steroid 5alpha-reductase.
Bratoeff E; Sainz T; Cabeza M; Heuze I; Recillas S; Pérez V; Rodríguez C; Segura T; Gonzáles J; Ramírez E
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):48-56. PubMed ID: 17629476
[TBL] [Abstract][Full Text] [Related]
51. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
52. Stimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells.
Kayampilly PP; Wanamaker BL; Stewart JA; Wagner CL; Menon KM
Endocrinology; 2010 Oct; 151(10):5030-7. PubMed ID: 20810561
[TBL] [Abstract][Full Text] [Related]
53. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
54. Precise quantitation of 5alpha-reductase type 1 mRNA by RT-PCR in rat liver and its positive regulation by testosterone and dihydrotestosterone.
Torres JM; Ortega E
Biochem Biophys Res Commun; 2003 Aug; 308(3):469-73. PubMed ID: 12914773
[TBL] [Abstract][Full Text] [Related]
55. 5Alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells.
Poletti A; Rampoldi A; Piccioni F; Volpi S; Simeoni S; Zanisi M; Martini L
J Neuroendocrinol; 2001 Apr; 13(4):353-7. PubMed ID: 11264723
[TBL] [Abstract][Full Text] [Related]
56. Seasonal expression of P450c17 and 5α-reductase-2 in the scented gland of male muskrats (Ondatra zibethicus).
Han W; Xie W; Zhang Y; Zhang F; Zhang H; Han Y; Yuan Z; Weng Q
Gen Comp Endocrinol; 2017 Dec; 254():60-67. PubMed ID: 28919450
[TBL] [Abstract][Full Text] [Related]
57. Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues.
Rocha EM; Wickham LA; da Silveira LA; Krenzer KL; Yu FS; Toda I; Sullivan BD; Sullivan DA
Br J Ophthalmol; 2000 Jan; 84(1):76-84. PubMed ID: 10611104
[TBL] [Abstract][Full Text] [Related]
58. Pre-receptor regulation of the androgen receptor.
Penning TM; Jin Y; Rizner TL; Bauman DR
Mol Cell Endocrinol; 2008 Jan; 281(1-2):1-8. PubMed ID: 18060684
[TBL] [Abstract][Full Text] [Related]
59. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
60. Developmental expression and regulation of aromatase- and 5alpha-reductase type I mRNA in the male and female mouse hypothalamus.
Karolczak M; Küppers E; Beyer C
J Neuroendocrinol; 1998 Apr; 10(4):267-74. PubMed ID: 9630396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
